×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NMRA – neumora therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NMRA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/25
04:32 pm
nmra
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Low
Report
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
3/19
07:27 pm
nmra
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Low
Report
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
3/16
07:00 am
nmra
Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026
High
Report
Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026
3/9
08:22 pm
nmra
Neumora Therapeutics (NMRA) Positioned to Capitalize on Blockbuster Opportunity [Yahoo! Finance]
Low
Report
Neumora Therapeutics (NMRA) Positioned to Capitalize on Blockbuster Opportunity [Yahoo! Finance]
3/4
05:57 am
nmra
Neumora Therapeutics Inc (NMRA) Sheds More Light on Phase 1b Study of NMRA-511 [Yahoo! Finance]
Neutral
Report
Neumora Therapeutics Inc (NMRA) Sheds More Light on Phase 1b Study of NMRA-511 [Yahoo! Finance]
2/17
07:23 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Medium
Report
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
2/4
07:00 am
nmra
Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
Low
Report
Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
1/13
05:44 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Medium
Report
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2025
07:00 am
nmra
neumora therapeutics, inc.
MISS
Report
-0.8%
neumora therapeutics, inc.
8/6/2025
04:05 pm
nmra
neumora therapeutics, inc.
BEAT
Report
3.8%
neumora therapeutics, inc.
5/12/2025
04:01 pm
nmra
neumora therapeutics, inc.
MISS
Report
-1.9%
neumora therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/19
05:07 pm
nmra
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Aurora Daljit Singh
Low
Report
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Aurora Daljit Singh
2/19
05:06 pm
nmra
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Pinto Joshua
Low
Report
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Pinto Joshua
2/19
05:05 pm
nmra
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: BERNS PAUL L
Medium
Report
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: BERNS PAUL L
2/19
05:04 pm
nmra
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Milligan Michael Lee
Medium
Report
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Milligan Michael Lee
2/19
04:37 pm
nmra
Form SCHEDULE 13G Neumora Therapeutics, Filed by: Invus Global Management, LLC
Low
Report
Form SCHEDULE 13G Neumora Therapeutics, Filed by: Invus Global Management, LLC
2/17
04:42 pm
nmra
Form SCHEDULE 13G/A Neumora Therapeutics, Filed by: K2 HealthVentures Equity Trust LLC
Low
Report
Form SCHEDULE 13G/A Neumora Therapeutics, Filed by: K2 HealthVentures Equity Trust LLC
2/17
04:27 pm
nmra
Form 144 Neumora Therapeutics, Filed by: Pinto Joshua
Low
Report
Form 144 Neumora Therapeutics, Filed by: Pinto Joshua
2/17
04:25 pm
nmra
Form 144 Neumora Therapeutics, Filed by: BERNS PAUL L
Low
Report
Form 144 Neumora Therapeutics, Filed by: BERNS PAUL L
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: